Clinical trial Recruiting at 1 site Observational Ages 18 and up

Using MRI to detect bleeding in plaques for stroke diagnosis

Official title: Plaque Imaging in Routine Care to Detect Intraplaque Hemorrhage

Run by Ludwig-Maximilians - University of Munich · NCT06749106 · Data updated 2026-11-12

This study is trying to see if using MRI to find bleeding in artery plaques can help doctors better diagnose strokes, especially in patients who have unexplained strokes.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment300 (estimated)
SponsorLudwig-Maximilians - University of Munich
Academic / other
Locations1 site (Munich)
StatusRecruiting
StartedJanuary 16, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedJanuary 24, 2025
Trial IDNCT06749106 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients with acute ischemic stroke who have undergone non-contrast carotid MRI as part of their routine diagnostic work-up.

Probably not a fit

Patients with posterior circulation infarcts, bilateral ischemic infarcts, or those who have had prior carotid interventions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between intraplaque hemorrhage (IPH) detected by non-contrast MRI of the carotid artery and acute ischemic stroke events. By analyzing both prospective and retrospective data, the study seeks to determine if identifying IPH can enhance the diagnostic process for stroke patients, particularly those with cryptogenic strokes. The research focuses on integrating simpler imaging protocols into routine clinical practice to better stratify stroke etiology and identify patients at risk for recurrent strokes.

Why it matters

Potential benefit: If successful, this study could lead to improved diagnosis and targeted treatment for patients experiencing acute ischemic strokes.

How similar studies have gone: Previous studies have indicated that imaging features related to plaque vulnerability can be associated with stroke events, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with acute ischemic stroke
* Availability of non-contrast carotid MRI scans obtained through routine diagnostic work-up

Exclusion Criteria:

* Infarct in the posterior circulation or bilateral ischemic infarcts
* Time between symptom onset and non-contrast carotid MRI \> 10 days
* Prior stenting of a carotid artery or carotid endarterectomy
* Age \< 18 years
* Life expectancy \< 1 year
* Inability to provide written informed consent

This eligibility criteria apply for the prospective part of the PARADE study.

Where it's running

  • Institute for Stroke and Dementia Research
    Munich, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.